When we directly compared the exogenous level of PIP4K2A in GBM that was within the physiological range of endogenous PIP4K2A level in NPCs, we discovered that overexpression of PIP4K2A consistently attenuated phosphorylation of AKT (Fig. S3 C). The gene discussed is AKT1; the disease is glioblastoma.